Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,082.30
+3.20 (0.30%)
Jan 7, 2026, 12:10 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 171.2 billion as of January 6, 2026. Its market cap has decreased by -1.02% in one year.
Market Cap
171.20B
Enterprise Value
193.59B
Revenue
76.18B
Ranking
n/a
PE Ratio
35.84
Stock Price
1,082.30
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 171.20B, an increase of 41,990.52%. That is a compound annual growth rate of 26.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 169.52B | -0.42% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 927.70B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |